At present, advances in therapeutic modalities make HSCT available for elderly patients and patients with more advanced disease; thus, it is likely that increasing frequencies of viral and fungal infections may crucially interfere with the future outcome of HSCT. [4] [5] [6] A 64-year-old woman with renal cell carcinoma was referred to our centre for allogeneic HSCT. At diagnosis, metastases were found in the lungs as well as in a paraaortic lymph node. Owing to the bad prognosis of metastasized renal cell carcinoma, she was accepted for allogeneic HSCT using a matched unrelated donor (10/10) to achieve graftvs-tumour effect. At 6 months after extirpation of the primary tumour (right-sided nephrectomy), she was in good physical shape and was admitted to our ward for transplantation.
The patient received a reduced-intensity conditioning regimen consisting of fludarabine (30 mg/m 2 ) for 5 days followed by CY (60 mg/kg) for 2 days and thymoglobulin (4 mg/kg) for 4 days. Immunosuppression was composed of tacrolimus (trough level 5-10 ng/ml) and sirolimus (trough level 5 ng/ml). During the conditioning, the patient started to complain of nausea and frontal headache, especially around the right eye and over the right zygomatic arch. At transplantation, the patient was neutropenic (ANC o0.5 Â 10 9 /l) and received 4.7 Â 10 6 CD34 þ PBSC. The following day, she developed signs of infection (body temperature 39 1C, C-reactive protein 166 mg/l) and treatment with a broad-spectrum antibiotic (cefepime) was initiated. Analyses of blood, urine or cerebrospinal fluid did not reveal any bacteria, viruses or fungi. Moreover, computed tomography scanning of the head excluded cerebral haemorrhage, sinus thrombosis and sinusitis ( Figure 1a ). A few days later, the fever disappeared and the C-reactive protein normalized; however, the patient kept on complaining of severe headache. Suddenly, on day þ 12, a bilateral marked periorbital oedema arose, which was more pronounced around the right eye. Simultaneously, the C-reactive protein increased to 198 mg/l compared with 43 mg/l 5 days earlier, and consequently the treatment with broad-spectrum antibiotics was changed from cefepime to meropenem. The dentist, the otorhinolaryngologist, as well as the ophthalmologist, were all consulted; no dental infections were localized; there were no signs of visual impairment, increased intracranial or intraorbital pressure, but there were signs of moderate sinusitis, including strong suspicion of ethmoiditis. At the time, meropenem was regarded as sufficient treatment by the otorhinolaryngologist. Furthermore, differential diagnoses such as drug side effects caused by tacrolimus and/or sirolimus were considered. Sirolimus was discontinued and tacrolimus was changed to CYA (trough level 200-300 ng/ml).
Two weeks post transplant the patient recovered from neutropenia, and simultaneously the headache as well as the periorbital oedema progressed. At that time, the pain was more or less resistant to all analgetic drugs, including high doses of morphine (450 mg daily). A new computed tomography scan (day þ 13) of the head and sinuses showed severe right-sided ethmoiditis, sphenoiditis and exophthalmus of the right eye (Figure 1b) . The radiologist suggested fungal sinusitis and antifungal treatment (voriconazole) was started. The following day, the right ethmoid sinus was surgically drained and mucosa was retrieved for microbiological analyses, but cultures, PCR and direct microscopy could not reveal any microorganism(s).
Suddenly, the patient started to complain about impaired vision of her right eye (day þ 18). The same day, she was examined by an ophthalmologist, who found her completely blind in the right eye. The sudden blindness was caused by an apex syndrome, that is, swelling of the intraorbital soft tissue, resulting in anoxia and probably irreversible damage to the optic nerve. During the next 7 days, the patient still suffered from severe headache and she was kept on both voriconazole and meropenem. Thereafter, the headache promptly disappeared, and the patient slowly recovered the ability to detect light with her right eye.
At 4 weeks after transplantation, the immunosuppressive regimen was switched back to tacrolimus/sirolimus, meropenem was discontinued, and the patient was discharged. The anti-fungal treatment with voriconazole was continued for 3 months. However, the aetiology of the sinusitis and the apex syndrome was still hard to elucidate. The radiology findings strongly suggested fungal sinusitis, but according to the EORTC/MSG Consensus Group, 7 this finding alone is only consistent with the lowest suspicion of fungal infection. Other differential diagnoses, such as cerebral venous thrombosis, drug side effects, and bacterial or viral infections, were already ruled out or considered less likely than fungal infection. The question was also raised whether the surgical drainage of the ethmoid sinus may have induced an apex syndrome, but according to the otorhinolaryngologist, this was unlikely and it is also contradicted by the presence of exophthalmus before surgery (Figure 1b) . Fortunately, the patient's vision improved continuously, and 4 months after transplantation the ophthalmologist reported greatly improved vision (visual accuracy 0.6) of the right eye. After transplant, there were no signs of acute or chronic GVHD, although the patient received four escalating donor lymphocyte infusions (1.0 Â 10 6 , 1.7 Â 10 6 , 3.5 Â 10 6 , 1.6 Â 10 8 CD3 þ cells/kg). Unfortunately, there was no graft-vs-tumour effect; the renal cell carcinoma progressed with skeletal as well as lung metastases and the patient died 9 months after transplant.
Apex syndrome is a rare event that may be associated with fungal sinusitis. 8, 9 In the literature, there are no earlier cases after HSCT published, but there are similar cases reported in other immunocompromised disorders such as AIDS. 10 In the future, we believe that the risk of apex syndrome must be considered in neutropenic patients with severe headache in close proximity to the eyes. Moreover, as the sinusitis is disguised during neutropenia, we suggest pre-emptive antifungal therapy to reduce the risk of apex syndrome and irreversible visual impairment.
